BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Warfield KL, Schaaf KR, DeWald LE, Spurgers KB, Wang W, Stavale E, Mendenhall M, Shilts MH, Stockwell TB, Barnard DL, Ramstedt U, Das SR. Lack of selective resistance of influenza A virus in presence of host-targeted antiviral, UV-4B. Sci Rep 2019;9:7484. [PMID: 31097731 DOI: 10.1038/s41598-019-43030-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Karade SS, Kolesnikov A, Treston AM, Mariuzza RA. Identification of Endoplasmic Reticulum α-Glucosidase I from a Thermophilic Fungus as a Platform for Structure-Guided Antiviral Drug Design. Biochemistry 2022. [PMID: 35476408 DOI: 10.1021/acs.biochem.2c00092] [Reference Citation Analysis]
2 Kohli E, Causse S, Baverel V, Dubrez L, Borges-Bonan N, Demidov O, Garrido C. Endoplasmic Reticulum Chaperones in Viral Infection: Therapeutic Perspectives. Microbiol Mol Biol Rev 2021;:e0003521. [PMID: 34643441 DOI: 10.1128/MMBR.00035-21] [Reference Citation Analysis]
3 Urbaniak K, Kowalczyk A, Pomorska-mól M, Kwit K, Markowska-daniel I. Effect of serial in vivo passages on the adaptation of H1N1 avian influenza virus to pigs. Journal of Veterinary Research 2022;66:9-19. [DOI: 10.2478/jvetres-2022-0013] [Reference Citation Analysis]
4 Goulding LV, Yang J, Jiang Z, Zhang H, Lea D, Emes RD, Dottorini T, Pu J, Liu J, Chang KC. Thapsigargin at Non-Cytotoxic Levels Induces a Potent Host Antiviral Response that Blocks Influenza A Virus Replication. Viruses 2020;12:E1093. [PMID: 32992478 DOI: 10.3390/v12101093] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
5 Zou J, Yu L, Zhu Y, Yang S, Zhao J, Zhao Y, Jiang M, Xie S, Liu H, Zhao C, Zhou H. Transportin-3 Facilitates Uncoating of Influenza A Virus. Int J Mol Sci 2022;23:4128. [PMID: 35456945 DOI: 10.3390/ijms23084128] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Tampere M, Pettke A, Salata C, Wallner O, Koolmeister T, Cazares-Körner A, Visnes T, Hesselman MC, Kunold E, Wiita E, Kalderén C, Lightowler M, Jemth AS, Lehtiö J, Rosenquist Å, Warpman-Berglund U, Helleday T, Mirazimi A, Jafari R, Puumalainen MR. Novel Broad-Spectrum Antiviral Inhibitors Targeting Host Factors Essential for Replication of Pathogenic RNA Viruses. Viruses 2020;12:E1423. [PMID: 33322045 DOI: 10.3390/v12121423] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
7 King CR, Tessier TM, Dodge MJ, Weinberg JB, Mymryk JS. Inhibition of Human Adenovirus Replication by the Importin α/β1 Nuclear Import Inhibitor Ivermectin. J Virol 2020;94:e00710-20. [PMID: 32641484 DOI: 10.1128/JVI.00710-20] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
8 Franco EJ, Pires de Mello CP, Brown AN. Antiviral Evaluation of UV-4B and Interferon-Alpha Combination Regimens against Dengue Virus. Viruses 2021;13:771. [PMID: 33925551 DOI: 10.3390/v13050771] [Reference Citation Analysis]
9 Si L, Bai H, Oh CY, Jin L, Prantil-Baun R, Ingber DE. Clinically Relevant Influenza Virus Evolution Reconstituted in a Human Lung Airway-on-a-Chip. Microbiol Spectr 2021;9:e0025721. [PMID: 34523991 DOI: 10.1128/Spectrum.00257-21] [Reference Citation Analysis]
10 Li B, Clohisey SM, Chia BS, Wang B, Cui A, Eisenhaure T, Schweitzer LD, Hoover P, Parkinson NJ, Nachshon A, Smith N, Regan T, Farr D, Gutmann MU, Bukhari SI, Law A, Sangesland M, Gat-Viks I, Digard P, Vasudevan S, Lingwood D, Dockrell DH, Doench JG, Baillie JK, Hacohen N. Genome-wide CRISPR screen identifies host dependency factors for influenza A virus infection. Nat Commun 2020;11:164. [PMID: 31919360 DOI: 10.1038/s41467-019-13965-x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 33] [Article Influence: 19.0] [Reference Citation Analysis]
11 Tang H, Abouleila Y, Si L, Ortega-Prieto AM, Mummery CL, Ingber DE, Mashaghi A. Human Organs-on-Chips for Virology. Trends Microbiol 2020;28:934-46. [PMID: 32674988 DOI: 10.1016/j.tim.2020.06.005] [Cited by in Crossref: 39] [Cited by in F6Publishing: 31] [Article Influence: 19.5] [Reference Citation Analysis]
12 Evans DeWald L, Starr C, Butters T, Treston A, Warfield KL. Iminosugars: A host-targeted approach to combat Flaviviridae infections. Antiviral Res 2020;184:104881. [PMID: 32768411 DOI: 10.1016/j.antiviral.2020.104881] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
13 Warfield KL, Alonzi DS, Hill JC, Caputo AT, Roversi P, Kiappes JL, Sheets N, Duchars M, Dwek RA, Biggins J, Barnard D, Shresta S, Treston AM, Zitzmann N. Targeting Endoplasmic Reticulum α-Glucosidase I with a Single-Dose Iminosugar Treatment Protects against Lethal Influenza and Dengue Virus Infections. J Med Chem 2020;63:4205-14. [DOI: 10.1021/acs.jmedchem.0c00067] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
14 Shearer J, Wolfe G, Sampath A, Warfield KL, Kaufman B, Ramstedt U, Treston A. Investigational New Drug Enabling Nonclinical Safety Pharmacology Assessment of the Iminosugar UV-4, a Broad-Spectrum Host-Targeted Antiviral Agent. Int J Toxicol 2022;:10915818211072842. [PMID: 35227115 DOI: 10.1177/10915818211072842] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Shearer J, Wolfe G, Sampath A, Warfield KL, Kaufman B, Ramstedt U, Treston A. Investigational New Drug Enabling Nonclinical Safety Assessment of the Iminosugar UV-4, a Broad-Spectrum Host-Targeted Antiviral Agent. Int J Toxicol. [DOI: 10.1177/10915818221077225] [Reference Citation Analysis]
16 Mahajan S, Choudhary S, Kumar P, Tomar S. Antiviral strategies targeting host factors and mechanisms obliging +ssRNA viral pathogens. Bioorg Med Chem 2021;46:116356. [PMID: 34416512 DOI: 10.1016/j.bmc.2021.116356] [Reference Citation Analysis]
17 Kumar N, Sharma S, Kumar R, Tripathi BN, Barua S, Ly H, Rouse BT. Host-Directed Antiviral Therapy. Clin Microbiol Rev 2020;33:e00168-19. [PMID: 32404434 DOI: 10.1128/CMR.00168-19] [Cited by in F6Publishing: 9] [Reference Citation Analysis]